Invention Grant
- Patent Title: Hyperblebbing Shigella strains
-
Application No.: US15094077Application Date: 2016-04-08
-
Publication No.: US11339367B2Publication Date: 2022-05-24
- Inventor: Christiane Gerke , Francesco Berlanda Scorza , Allan Saul , Luana Maggiore
- Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
- Applicant Address: BE Rixensart
- Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee Address: BE Rixensart
- Agency: Loza & Loza, LLP
- Agent Michelle L. Lewis
- Priority: GB0917002 20090928
- Main IPC: C12N1/20
- IPC: C12N1/20 ; C07K14/25 ; A61K39/00 ; A61K35/12
Abstract:
Hyperblebbing Shigella strains are generated by disrupting one or more components of the Tol-Pal system. The blebs from these strains are useful immunogens for vaccination. The individual proteins found in these blebs can also be used as immunogens.
Public/Granted literature
- US20160289632A1 Hyperblebbing Shigella Strains Public/Granted day:2016-10-06
Information query
IPC分类:
